On the recordSeptember 18, 2014
GAIN did not fully fix the problem, and much more is needed if we are to incentivize the type of drug development needed to combat this global threat.
Source
congress.govGAIN did not fully fix the problem, and much more is needed if we are to incentivize the type of drug development needed to combat this global threat.
Pitts acknowledges that further action is necessary beyond the GAIN Act to address antibiotic resistance.
Share
More from Joe Pitts
It seems illogical that the USDA would be given the exclusive authority to oversee and regulate catfish only while the FDA regulates all other seafood.
The time of 10 o'clock having arrived, I will call this subcommittee meeting to order.
So, moving forward, the committee welcomes feedback on how we can improve care for children with medical complexity without disrupting the successful approaches already in place.
Both the FDA and the General Accountability Office agree that there is no food safety justification for this regulatory divide.